Glucagon-like peptide-1 receptor

被引：1

作者：

Krashes, Michael ^{[1
]}

机构：

[1] NIH, Diabet Endocrinol & Obes Branch, Natl Inst Diabet & Digest & Kidney Dis, Bethesda, MD 20892 USA

来源：

CURRENT BIOLOGY | 2024年 / 34卷 / 23期

关键词：

D O I：

10.1016/j.cub.2024.10.039

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：R1163 / R1164

页数：2

共 10 条

[1] Glucagon-like peptide-1 (7-36) amide as a novel neuropeptide [J].

Blázquez, E ;

Alvarez, E ;

Roncero, I ;

Rodríguez-Fonseca, F ;

Chowen, JA ;

Zueco, JA .

MOLECULAR NEUROBIOLOGY, 1998, 18 (02) :157-173

[2] Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1 [J].

Drucker, Daniel J. .

CELL METABOLISM, 2018, 27 (04) :740-756

[3] Good Health and Well-being for All in 2020 [J].

Gabel, Shirley ;

Mapp, Susan .

JOURNAL OF HUMAN RIGHTS AND SOCIAL WORK, 2020, 5 (01) :1-2

[4] Dissociable hindbrain GLP1R circuits for satiety and aversion [J].

Huang, Kuei-Pin ;

Acosta, Alisha A. ;

Ghidewon, Misgana Y. ;

McKnight, Aaron D. ;

Almeida, Milena S. ;

Nyema, Nathaniel T. ;

Hanchak, Nicholas D. ;

Patel, Nisha ;

Gbenou, Yenoukoume S. K. ;

Adriaenssens, Alice E. ;

Bolding, Kevin A. ;

Alhadeff, Amber L. .

NATURE, 2024, 632 (8025) :585-+

[5] Tirzepatide Once Weekly for the Treatment of Obesity [J].

Jastreboff, Ania M. ;

Aronne, Louis J. ;

Ahmad, Nadia N. ;

Wharton, Sean ;

Connery, Lisa ;

Alves, Breno ;

Kiyosue, Arihiro ;

Zhang, Shuyu ;

Liu, Bing ;

Bunck, Mathijs C. ;

Stefanski, Adam .

NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (03) :205-216

[6] Peripheral and Central GLP-1 Receptor Populations Mediate the Anorectic Effects of Peripherally Administered GLP-1 Receptor Agonists, Liraglutide and Exendin-4 [J].

Kanoski, Scott E. ;

Fortin, Samantha M. ;

Arnold, Myrtha ;

Grill, Harvey J. ;

Hayes, Matthew R. .

ENDOCRINOLOGY, 2011, 152 (08) :3103-3112

[7] A role for glucagon-like peptide-1 in the central regulation of feeding [J].

Turton, MD ;

OShea, D ;

Gunn, I ;

Beak, SA ;

Edwards, CMB ;

Meeran, K ;

Choi, SJ ;

Taylor, GM ;

Heath, MM ;

Lambert, PD ;

Wilding, JPH ;

Smith, DM ;

Ghatei, MA ;

Herbert, J ;

Bloom, SR .

NATURE, 1996, 379 (6560) :69-72

[8] Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity The STEP 3 Randomized Clinical Trial [J].

Wadden, Thomas A. ;

Bailey, Timothy S. ;

Billings, Liana K. ;

Davies, Melanie ;

Frias, Juan P. ;

Koroleva, Anna ;

Lingvay, Ildiko ;

O'Neil, Patrick M. ;

Rubino, Domenica M. ;

Skovgaard, Dorthe ;

Wallenstein, Signe O. R. ;

Garvey, W. Timothy .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (14) :1403-1413

[9] Once-Weekly Semaglutide in Adults with Overweight or Obesity [J].

Wilding, John P. H. ;

Batterham, Rachel L. ;

Calanna, Salvatore ;

Davies, Melanie ;

Van Gaal, Luc F. ;

Lingvay, Ildiko ;

McGowan, Barbara M. ;

Rosenstock, Julio ;

Tran, Marie T. D. ;

Wadden, Thomas A. ;

Wharton, Sean ;

Yokote, Koutaro ;

Zeuthen, Niels ;

Kushner, Robert F. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (11) :989-1002

[10] Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes:: a parallel-group study [J].

Zander, M ;

Madsbad, S ;

Madsen, JL ;

Holst, JJ .

LANCET, 2002, 359 (9309) :824-830

← 1 →